















【背景】心血管疾患は、Chronic kidney disease (CKD)患者にとって主要な死因であり、





危険因子を検索する。【方法】当院関連単一施設で 2006 年 1 月 1 日～12 月 31 日に外
来血液透析を行った 300 名について、CTR と総死亡、心血管死亡の関係を後ろ向きに
調査した。【結果】平均観察期間は、4.59±1.93 年で、観察開始時の年間平均 CTRによ
って 3 分位に分けたところ、総死亡における累積生存率は 3 群間で有意差を認めた
(P=0.0419)。また、CTRは、年齢、陳旧性心筋梗塞の既往、血清 phosphate 値、血清C-reactive 




































Renin-Angiotensin System(RAS)阻害薬・昇圧薬・抗血小板薬・スタチン・vitamin D receptor 
activation(VDRA)の使用率、透析前の血算・生化学検査[Hemoglobin(Hb)、アルブミン、
尿素窒素、phosphate(P)、補正 calcium(Ca)、中性脂肪、総コレステロール、High density 
lipoprotein(HDL)コレステロール、C-reactive protein(CRP)、Intact parathyroid hormone(PTH)、
Glycoalbumin(GA)、β2microglobulin(MG)、pH、HCO3]、ESA(erythropoiesis stimulating agent)
投与量、各種透析条件、及び週初めの HD 時の 12 週間の平均透析間体重増加率を検討
した。更に観察開始時 1年以内の経胸壁的心臓超音波検査における Left ventricular mass 
index(LVMI)、ejection fraction(EF)、Left atrial dimension(LAD)、Left ventricular end-systolic 
diameter(LVDs)、 Left ventricular end-diastolic diameter(LVDd)、 interventricular septal 
thickness(IVST)、Left ventricular posterior wall thickness(LVPWT)についても観察項目とし
た。 
 
Evaluation of Cardiothoracic Ratio by chest radiograph 
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【Background】Cardiovascular disease is the major cause of death in patients with chronic 
kidney disease and heart failure is the primary cause of death in patients on hemodialysis (HD) 
in Japan. It is important to control proper fluid volume and adjust Dry Weight (DW) to prevent 
cardiovascular event occurrence and progression in HD patients. Cardiothoracic ratio (CTR) is 
one of the useful indicators to evaluate DW. It is reported that CTR is independently associated 
with left ventricular hypertrophy and cardiac disturbance, but the clinical significance of CTR 
on the survival of HD patients remains unclear.【Method】We conducted a retrospective cohort 
study of 300 outpatients on HD in our affiliated institution from January 1 to December 31, 
2006 to evaluate the influence of CTR on all-cause and cardiovascular mortality.【Result】The 
mean observation period was 4.59±1.93 years. The annual average CTR was divided into three 
equal groups. Kaplan-Meier analysis showed that all-cause mortality was significantly different 
in the 3 groups (P=0.0419, log-rank test). Spearman correlation analysis demonstrated that CTR 
was positively correlated with age, old myocardial infarction, serum phosphate, serum 
C-reactive protein and left ventricular mass index (LVMI) and CTR was negatively correlated 
with anemia and serum albumin. In multivariate analysis, male, hypoalbuminemia and LVMI 
were significantly associated with all-cause and cardiovascular mortality, but CTR was not 
significantly associated with either.【Conclusion】CTR is not significantly associated with 
all-cause mortality or cardiovascular mortality in HD patients. 
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 図. 1 総死亡におけるカプランマイヤー生存曲線 
ログランク検定 P=0.0419 




図. 2 心血管死亡におけるカプランマイヤー生存曲線 
ログランク検定 P=0.0757 



























































































0.4998 0.8505 0.8311 0.5000 
Diabetes 109 40 38 31 0.382 0.9549 0.3803 0.5524 
Smoking 113 47 35 31 0.0527 0.1973 0.0539 0.8201 
Hyperten
tion 















173 52 39 82 0.0304 0.7895 0.1752 0.0383 
RAS 
inhibiter 
113 42 42 29 0.0915 1.0000 0.1664 0.1664 
Anti 
platelet 
210 67 70 73 0.6524 0.8987 0.6524 0.8987 



































































































































0.1114 0.8022 0.1216 0.3811 















0.0038 0.0436 0.0066 0.8014 
interdialy
tic 
4.32 4.18 4.15 4.62 







(1.54) (1.60) (1.55) (1.43) 
Deaths 72 21 19 32 0.0687 0.9468 0.1915 0.0994 
数値はすべて総数または平均(標準偏差)で示した 
SBP : systolic blood pressure, Hb : hemoglobin, Alb : serum albumin, Ca : calcium, P : 
phosphorus, TG : triglycerid, HDL : high density lipoprotein, CRP : C-reactive protein, PTH : 
parathyroid hormone, GA : glycoalbumin, VDRA : vitamin D receptor activation, EPO : 












































































































0.1629 0.6638 0.1631 0.6160 
数値はすべて平均(標準偏差)で示した 
LVDd : left ventricular end-diastolic diameter, LVDs : left ventricular end-systolic diameter, 
IVST : interventricular septal thickness, LVPWT : left ventricular posterior wall thickness, 
LAD : left atrial dimension, LVMI : left ventricular mass index, EF : ejection fraction 
 
表3 CTRと関連する因子の解析(スピアマン順位相関係数) 
 Age OMI Hb Alb P CRP LVMI 
CTR 0.2240** 0.1177* -0.1487** -0.1429* 0.1425* 0.1164* 0.3637** 
Age  0.0721 -0.1102 -0.3798** -0.2622** 0.0965 0.0547 
OMI   -0.0125 -0.0649 0.0465 0.1007 0.0791 
Hb    0.4330** 0.0395 -0.2285** -0.02 
Alb     0.1416* -0.3985** 0.0627 
P      0.0158 0.1508** 
CRP       0.0276 
*P < 0.05; **P < 0.001 
 
表4 総死亡におけるCox比例ハザード法による解析 





<0.0001 1.0632 1.0361 - 1.0910 
Gender 
(male vs female) 




0.0722 1.8904 0.9441 - 3.7849 
Hb 
(/1g/dL) 
0.0678 0.7729 0.5861 - 1.0191 
Alb 
(/1g/dL) 





0.0046 1.0560 1.0169 - 1.0965 
 
表5 心血管死亡におけるCox比例ハザード法による解析 





0.0774 1.0354 0.9962 – 1.0762 
Gender 
(male vs female) 




0.0606 2.1602 0.9663 – 4.8293 
Anti platelet 0.1655 1.9991 0.7510 – 5.3217 
Alb 
(/1g/dL) 
0.0018 0.1647 0.0530 - 0.5114 
P 
(/1mg/dL) 





0.0031 1.0814 1.0267 - 1.1390 
QB 
(/10ml/min) 
0.0250 0.7773 0.6236 - 0.9689 
Kt/v 
(/0.1) 
0.0016 1.3438 1.1189 - 1.6139 
VDRA 0.0787 0.5282 0.2592 – 1.0761 
 
 
